Dong-A Pharmaceutical's 'Duo Buster Mintball' Surpasses 1 Million Units Sold in First Year
Dong-A Pharmaceutical announced on May 13 that its dual-capsule oral care product, "Duo Buster Mintball," surpassed a cumulative sales milestone of 1 million units just one year after its launch in April last year.
Recently, the oral care market has been shifting beyond simply removing bad breath to prioritizing user experience and portability. As more consumers seek a quick refresh in everyday situations—such as after meals, before meetings, or ahead of dates—demand is growing for products that deliver immediate freshness and are easy to carry.
Amid these trends, Duo Buster Mintball has received positive feedback from consumers with its differentiated formulation technology and stylish package design.
Duo Buster Mintball utilizes a dual liquid capsule structure, providing a refreshing sensation both inside the mouth and again when swallowed. It also features a thin capsule covering technology called "Seamless," which minimizes any residual shell feeling during consumption.
The product package is designed to allow a ring to be attached, making it portable as a keyring on a bag or pouch. The expansion of oral care products from simple functional items to everyday self-care accessories has also received a positive response from consumers.
Riding on this popularity, Duo Buster Mintball was selected as "MD's PICK" at the "2025 Olive Young Awards" just eight months after its launch, further establishing itself as a trendy oral care item. It is currently available at major retail channels such as Olive Young and Costco.
A Dong-A Pharmaceutical representative stated, "Duo Buster Mintball has established itself among consumers as not just a simple oral candy, but as an everyday self-care routine item," and added, "We plan to continue introducing differentiated oral care products that cater to evolving consumer lifestyles."
Hot Picks Today
Even with High Oil Price Relief Payment, Additional 300,000 Won Per Person to Be Provided... Applications Open from the 18th in This Region
- "Those Who Hesitated at 3,000 Still Haven't Bought" 7 Trillion-Won Asset Manager Says "Opportunities Remain" [Investment Strategies of the Wealthy] ⑦
- Shin Ramyun Surpasses KRW 20 Trillion in Cumulative Sales, Marking a New Chapter in K-Ramen History
- Investment Warnings Surge... "Warning Light" Flashes as KOSPI Nears 8,000 Points
- 'Drugs to Prevent Aging' Enter Their First Target Year... First Patient Dosed in the US [New Path for Bio, Anti-Aging] ①
Meanwhile, Dong-A Pharmaceutical continues to introduce a variety of healthcare solutions based on its founding philosophy that 'every product we create must contribute to the health of the people.'
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.